Y-Intercept (HK)’s Verona Pharma VRNA Stock Holding History

Y-Intercept (HK)’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,552	Closed	-$379K	–	2018
2025 Q3	$379K	Sell	3,552 -64,804	-95%	-$6.77M	0.01%	1327
2025 Q2	$6.47M	Buy	68,356 +57,006	+502%	+$4.22M	0.16%	156
2025 Q1	$721K	Buy	+11,350	New	+$679K	0.05%	538
2024 Q4	–	Sell	-11,361	Closed	-$327K	–	1699
2024 Q3	$327K	Buy	+11,361	New	+$280K	0.02%	976
2024 Q1	–	Sell	-11,343	Closed	-$225K	–	1792
2023 Q4	$225K	Buy	+11,343	New	+$167K	0.02%	950

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Y-Intercept (HK)'s VRNA Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 3,552 shares — an estimated $379K sold.

Y-Intercept (HK) first reported a position in VRNA in Q4 2023 and held it in 5 quarters. The position peaked at $6.47M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Y-Intercept (HK) reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Y-Intercept (HK) sold 3,552 Verona Pharma shares in Q4 2025, an estimated $379K.
Y-Intercept (HK) first reported a position in Verona Pharma in Q4 2023 and held it in 5 quarters.
Y-Intercept (HK)'s Verona Pharma position peaked at $6.47M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.